Logo Image

Authors

Erica DiNapoli, OncLive
Erica DiNapoli

Erica DiNapoli is an Assistant Editor for OncLive®. She joined the company in 2020 and now assists in editing and publishing both videos and informational articles to the website; she also helps manage the social media platforms. Prior to joining MJH Life Sciences, she was a student at Monmouth University and held two marketing internships at United Teletech Financial Federal Credit Union and Trendsetter Media & Marketing.

Latest Article

Chasing Survival Benefit With Novel Systemic Strategies in Early-Stage NSCLC

Kaushal Parikh, MD, MBBS, highlights ongoing research exploring systemic approaches in early-stage non¬–small cell lung cancer and shares where future efforts are headed.

Erika N. Brown, BS, MS, PharmD
Latest Article

Triple Receptor-Negative Breast Cancer: Current and Future Treatments

Breast cancer is the number one malignancy diagnosed in women in the United States. In 2009, it was estimated that more than 190,000 individuals would be diagnosed with breast cancer and approximately 40,000 would die from the disease.

Erin A. Gillaspie, MD, MPH
Latest Article

Neoadjuvant Immunotherapy May Change Standard of Care in Early-Stage NSCLC

Wade T. Iams, MD, and Erin A. Gillaspie, MD, MPH, discuss the impact that immunotherapy has had on the treatment of patients with early-stage non–small cell lung cancer.

Erin Burns, PhD
Latest Article

Pandemic Intensifies the Struggle With Burnout in Cancer Field

The COVID-19 pandemic has added another burden, with growing evidence of its negative effects on the well-being of many cancer care providers.

Erin Crum, MPH
Latest Article

McKesson's Patient-Reported Outcomes Measure Will Track Improvements in Health-Related Social Needs

The use of patient-reported outcome measures—the gold standard in quality measurement—is crucial to building a patient-centered, value-based care system.

Erin F. Gillespie, MD, Neil Panjwani, BS, Arno J. Mundt, MD
Latest Article

eContour: Evidence-Based Interactive Contouring Resources at the Point of Care

eContour is a novel, web-based, interactive contouring resource that aims to facilitate access to decision support through high-yield radiation treatment recommendations that are free and available at the point of care.

Erin Hofstatter, MD
Latest Article

Clinical Utility of Emerging Molecular Diagnostics in Breast Cancer

The past decade of biomarker research has led to the introduction of several multigene prognostic tests that are now routinely used in clinical decision making to assist the se-lection of patients for adjuvant chemotherapy, and several other tests have emerged with potential clinical utility.

Erin M. Burns, PhD, MSPH
Latest Article

Advanced Practice Providers Are Poised to Boost Community Involvement in Clinical Trials

For those in the community setting, several barriers to clinical research prevent advanced care providers and their patients from taking part in experimental therapies.

Eugene Feit
Latest Article

The Downside to Beating the Odds

By now, I am supposed to be dead.

Eunice Wang, MD, Roswell Park Cancer Institute
Evan Wu, MD
Latest Article

Metastatic Cancer Is a Chronic Condition

Advancements in targeted therapy and immunotherapy have led to a rapidly increasing number of patients with metastatic cancer becoming patients with chronic cancer.

Evan Y. Yu, MD, Seattle Cancer Care
Evan Y. Yu, MD, Seattle Cancer Care Â
Evan Yu, MD, University of Washington
Everett E. Vokes, MD, University of Chicago Medicine
Everett Vokes, MD, University of Chicago Medicine
Ezra Cohen, MD, Moores Cancer Center
Ezra Cohen, MD, UC San Diego Moores Cancer Center
Ezra Cohen, MD, UCSD
Ezra Cohen, MD, University of Chicago
F. Anthony Greco, MD, Sarah Cannon Cancer Center
F. Nery Flores, MD
Latest Article

Focal Therapy Evolves Into More Precise Treatment in Prostate Cancer

Historically, the management of localized prostate cancer has centered on removal or ablation of the entire gland with either extirpative surgery or radiation. However, the subsequent unacceptable adverse events profile can be devastating and life altering for many patients.

FACP, University of Pittsburgh School of Medicine
Fadi Braiteh, MD, Comprehensive Cancer Centers of Nevada
Latest Article

Final Takeaways – Sequencing, Counseling, and Prevention

Weigh nivolumab–ipilimumab benefits versus immune toxicities in HCC, factoring patient comorbidities, access, preferences, and the urgent need for predictive biomarkers.

Fadi Braiteh, MD, CPI, CCC Nevada
Fadi Braiteh, MD, University of Nevada School of Medicine
Fadi S. Braiteh, MD
Faisal Musa, MD
Latest Article

Do We Still Need Physical Exams in the Era of Advanced Imaging Technologies?

Throughout fellowship, my experiences working with patients in clinic have taught me many lessons.

Faith Davies, MD, MBBCh, MRCP, FRCPath, University of Arkansas for Medical Sciences
Fard Johnmar
Latest Article

Wellsphere Blogger Flap Raises Questions about Content Ownership

It started with an e-mail to thousands of health bloggers from Dr. Geoff Rutledge, Chief Medical Information Officer at the health website Wellsphere.